Pedro Albajar Viñas

Dr. Pedro Albajar Viñas


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2010 in Nature
Verified
Journal Article
Closed access
JCJosé Rodrigues Coura
José Rodrigues Coura
PVPedro Albajar Viñas
Pedro Albajar Viñas

1 December 2015 in Interface - Comunicação, Saúde, Educação
Verified
Journal Article
Open access
PDF file
MSMariana Sanmartino
Mariana Sanmartino
AAAndrea Avaria
Andrea Avaria
JPJordi Gomez i Prat
Jordi Gomez i Prat
MBMa. Cristina Parada Barba
Ma. Cristina Parada Barba
PVPedro Albajar Viñas
Pedro Albajar Viñas
El artículo da cuenta de un estudio internacional realizado entre octubre de 2011 y enero de 2012, como fundamento para el diseño y elaboración de un material audiovisual (spot) con el objeto de sensibilizar y visibilizar la problemática del Chagas. La investigación, de carácter cualitativo, recogió los datos de 38 encuestas, respondidas por personas afectadas y especialistas en la temática. La información para cada grupo se ordenó según aspectos que las personas asociaban con la palabra Chagas, y dificultades, retos, desafíos y logros vinculados. Para cada punto se presenta un análisis de las respuestas, relatos y anécdotas relacionadas. Las conclusiones refuerzan la necesidad de conocer y dar a conocer las dificultades que viven las personas afectadas por el Chagas, considerando que se trata de una realidad que tiene diversas manifestaciones dependiendo del contexto.

19 February 2016 in Journal of Immigrant and Minority Health
Verified
Journal Article
Closed access
PDF file
IGIsabel Claveria Guiu
Isabel Claveria Guiu
JMJohanna Caro Mendivelso
Johanna Caro Mendivelso
HEHakima Ouaarab Essadek
Hakima Ouaarab Essadek
MMMaria Asunción González Mestre
Maria Asunción González Mestre
PVPedro Albajar Viñas
Pedro Albajar Viñas
JPJordi Gomez i Prat
Jordi Gomez i Prat

21 November 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ASAntoni Soriano-Arandes
Antoni Soriano-Arandes
LBLuca Basile
Luca Basile
HOHakima Ouaarab
Hakima Ouaarab
ICIsabel Clavería
Isabel Clavería
JPJordi Gomez i Prat
Jordi Gomez i Prat
MJMireia Jané
Mireia Jané
Chagas disease (CD) is endemic in countries of continental Latin America. Congenital transmission is a major concern worldwide. In 2010, the Public Health Agency of Catalonia (ASPCAT) launched a screening protocol for Trypanosoma cruzi infection in pregnant women and their newborns. In 2012, ASPCAT detected appropriate follow-up of pregnant women but incomplete information about their offspring.

20 June 2019 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
JPJordi Gomez i Prat
Jordi Gomez i Prat
PPPaula Peremiquel-Trillas
Paula Peremiquel-Trillas
IGIsabel Claveria Guiu
Isabel Claveria Guiu
ECEstefa Choque
Estefa Choque
ISInés Oliveira Souto
Inés Oliveira Souto
CTCarlos Ascaso Terren
Carlos Ascaso Terren

6 January 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ABAnna Barbiero
Anna Barbiero
MMMartina Mazzi
Martina Mazzi
AMAntonia Mantella
Antonia Mantella
MTMichele Trotta
Michele Trotta
Gian Maria RossoliniGian Maria Rossolini
Gian Maria Rossolini
Lorenzo ZammarchiLorenzo Zammarchi
Lorenzo Zammarchi
The leading route of Chagas disease transmission in nonendemic countries is congenital. However, policies concerning screening, prevention, and management of congenital Chagas disease are rare in these settings. Since 2012, serological screening for Chagas disease should be provided for pregnant women at risk in Tuscany, Italy according to a Regional resolution. Due to difficulties in the implementation, in November 2019, a checklist aimed at identifying pregnant women at risk for Chagas disease was introduced in digital clinical records at Careggi University Hospital, Florence, Italy. In order to evaluate the effectiveness of the “Chagas checklist”, data about the number of deliveries by women at risk and their screening coverage between 2012 and June 2022 were collected. Out of 1348 deliveries by women at risk, 626 (47%) Trypanosoma cruzi serology tests were performed during the study period. The annual screening coverage increased from an average of 40.3% between 2012 and 2019 to 75.7% between 2020 and June 2022, underlining the big impact of the checklist. Four Chagas disease serological tests out of 626 (0.6%) resulted positive, corresponding to 2 affected women. No cases of congenital transmission occurred. The study showed that a simple digital tool led to a tangible improvement in the coverage of the screening program; its application in a setting where digital charts are available will contribute to the control and elimination of congenital Chagas disease.